SCHEMBL5743306

SCHEMBL5743306

CCCCCCCCCCCCCCCC(=O)Nc1cccc(COc2cc(-c3cc4ccccc4[nH]3)n[nH]2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ITK Q08881 1/20 0.42
SPHK2 Q9NRA0 1/20 0.42
SPHK1 Q9NYA1 1/20 0.42
CNR2 P34972 1/20 0.41
AURKA O14965 1/20 0.41
AURKB Q96GD4 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ABL1 P00519 1/20 0.41
BCR P11274 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4112674 0.86 ITK (0.51) LMNANPC1RAB9ASMN1; SMN2ITK
SCHEMBL4112799 0.77 AURKA (0.49) NPC1RAB9AITKCNR2AURKA
SCHEMBL13650125 0.70 ITK (0.52) LMNANPC1RAB9ASMN1; SMN2ITK
SCHEMBL8102853 0.70 SPHK2 (0.60) LMNANPC1RAB9ASMN1; SMN2SPHK2
SCHEMBL4120358 0.69 AURKA (0.46) ITKAURKAAURKB
SCHEMBL29796263 0.68 HDAC3 (0.64) LMNANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL28467935 0.68 HDAC3 (0.64) LMNANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL11901010 0.66 LMNA (0.69) LMNANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL11803925 0.66 HDAC3 (0.61) LMNANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9263124 0.65 PPARA (0.60) LMNANPC1RAB9ASMN1; SMN2CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633738-A2 NOVEL INDOLE DERIVATIVES, METHOD OF PREPARING SAME IN THE FORM OF MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND, IN PARTICULAR, KDR INHIBITORS Aventis Pharma S.A. (FR) 2006-03-15 EP disclosed
WO-2004096792-A2 NOVEL INDOLE DERIVATIVES, METHOD OF PREPARING SAME IN THE FORM OF MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND, IN PARTICULAR, KDR INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-11-11 WO disclosed